Mounjaro Price Comparison UK: Costs and Safety

Mounjaro price comparison in the UK reveals significant variation across private providers, with a single KwikPen (one month's supply) typically ranging from around £130 to over £250 depending on dose strength and what is included in the service. Understanding what drives these differences, how private costs compare to NHS access routes, and what safety checks to carry out before committing to a provider is essential. This guide covers all of these areas to help you make an informed, safe decision about accessing tirzepatide treatment in the UK.

What does Mounjaro actually cost across UK providers right now?

A single Mounjaro KwikPen (four weekly doses) typically costs between roughly £130 and over £250 at UK private providers, with higher dose strengths costing more. Prices vary by provider and do not always include consultation fees, delivery or pen needles.

Private Mounjaro prices in the UK vary considerably depending on the dose strength and the provider, but a single KwikPen (which contains four weekly doses and is therefore a month's supply) is typically priced somewhere in the range of roughly £130 to over £250 per pen at private online pharmacies and clinics, with higher dose strengths generally costing more. This range is indicative only: it reflects prices observed at a selection of UK online providers and clinics, does not include all possible additional costs (such as consultation fees, delivery or pen needles where charged separately), and will change over time as providers update their pricing. Always confirm the current price directly with the provider before committing.

Mounjaro is available in six dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg weekly, as listed in the UK Summary of Product Characteristics (SmPC). Because patients typically start at the lowest strength and titrate upward over several months, the monthly cost will change over the course of treatment.

The BNF carries a list price for one KwikPen, but this is a trade list price and does not represent what a private patient pays at the point of dispensing, nor is it an NHS prescription charge. It is included here only to illustrate that private retail prices are substantially above the list price, and it should not be used as a guide to what you will actually pay.

It is important to understand what the price should include. A legitimate private service will incorporate a clinical consultation with a registered prescriber, an initial assessment of eligibility and ongoing monitoring, not just the medication itself. Bolt Pharmacy is a GPhC-registered online pharmacy offering weight-management consultations, with prescriber review and pharmacist support, and Mounjaro is one option a prescriber may consider where it is clinically appropriate. Comparing headline figures without accounting for what is included in the service can give a misleading picture of true cost, so always ask for a full breakdown before committing.

Why do prices vary so much between clinics and online services?

Prices vary because providers bundle different combinations of services, including consultations, monitoring and pharmacist support, into their headline figure. Dose strength, operational overheads and business model also affect the final cost.

Mounjaro prices differ between providers primarily because the headline figure reflects different combinations of services, overheads and business models rather than differences in the medicine itself. The medicine dispensed must be the same MHRA-authorised product regardless of where it is obtained, but what surrounds it varies enormously. Some providers bundle the consultation fee, prescriber review, ongoing monitoring check-ins and pharmacist support into a single monthly price. Others charge separately for each element, meaning a lower advertised medication price may be accompanied by additional fees for the clinical assessment, follow-up appointments or delivery.

Operational costs also differ between providers. A large online pharmacy with automated systems may have lower per-patient overheads than a specialist obesity clinic with face-to-face appointments and dietitian input. Neither model is inherently better or worse, but they serve different clinical needs. A patient with complex comorbidities may benefit from more intensive clinical oversight, which will typically cost more. Conversely, a straightforward case managed safely through an asynchronous online consultation may be appropriately served by a lower-cost digital pathway, provided the prescriber is properly registered and the pharmacy is regulated.

Dose strength is another driver of price variation at many providers, though some services use flat pricing across all strengths. Because Mounjaro is titrated gradually, a patient at 2.5 mg weekly may pay less per pen than one who has reached 10 mg or 15 mg, depending on the provider's pricing structure. Providers who advertise a single low price may be quoting the starting dose only, so it is worth asking what the cost will be at the maintenance dose you are likely to reach. You should also ask about any additional costs not included in the headline price, such as delivery charges, cold-chain packaging, pen needles, sharps disposal bins and any fees for follow-up appointments or cancellation.

Is cheaper Mounjaro always safe, or are there risks to watch for?

A lower price is not automatically unsafe, but patients must only obtain Mounjaro from a GPhC- or PSNI-registered pharmacy dispensing an MHRA-authorised product. Counterfeit injectable GLP-1 medicines have been identified in the UK and carry serious risks.

A lower price is not automatically a safety concern, but certain cost-cutting practices do carry genuine risks that patients should be aware of. The most significant risk is obtaining tirzepatide from a source that is not a registered pharmacy dispensing an MHRA-authorised product. Counterfeit or unlicensed injectable products have been identified in the UK market, and these carry serious risks including contamination, incorrect dosing and unknown ingredients. The MHRA has issued warnings about unlicensed and counterfeit GLP-1 medicines, and patients should never purchase Mounjaro from an unregistered online seller, regardless of price.^[3]

In Great Britain, legitimate online pharmacies must be registered with the General Pharmaceutical Council (GPhC). In Northern Ireland, the equivalent regulator is the Pharmaceutical Society of Northern Ireland (PSNI). You can verify a pharmacy's registration directly on the GPhC register at pharmacyregulation.org or the PSNI register at psni.org.uk. A prescriber issuing the prescription must also be registered with the General Medical Council (gmc-uk.org), the Nursing and Midwifery Council, or another appropriate regulatory body.

A further safety concern with very low-cost services is the adequacy of clinical assessment. NICE guidance on weight management emphasises that pharmacological treatment should be initiated only after a proper assessment of BMI, comorbidities, previous weight-loss attempts and contraindications.^[6][7] A service that issues a prescription without a meaningful clinical review is not providing safe care, regardless of price.

If you experience a suspected adverse effect from Mounjaro, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Contact your GP if you have concerns about your treatment, or call NHS 111 for urgent advice.

How does the private cost compare to any NHS access routes?

NHS access to Mounjaro in England is available through specialist weight management services for patients meeting NICE criteria, with standard prescription charges applying; prescriptions are free in Scotland, Wales and Northern Ireland. Waiting times and local availability vary, making private treatment the only realistic option for some patients.

NHS access to Mounjaro is available in England through a structured pathway, but it is not universally available and eligibility criteria are specific. NICE has recommended tirzepatide (Mounjaro) for use within NHS England's specialist weight management services for adults who meet defined criteria relating to BMI and the presence of at least one weight-related comorbidity.^[4] Access is commissioned by integrated care boards (ICBs) in England, and availability varies by local area.^[4] NHS Scotland, NHS Wales and Health and Social Care in Northern Ireland commission weight management services separately, and access routes and criteria differ across the four nations.

For patients who do qualify for NHS treatment in England, the standard NHS prescription charge applies. Prescription charges apply only in England; prescriptions are free of charge in Scotland, Wales and Northern Ireland.^[8] In England, a prepayment certificate (PPC) is available for those who require multiple prescriptions and can reduce the overall cost significantly.^[9][10] Current NHS prescription charge and PPC fee information is published by the NHS Business Services Authority (NHSBSA) and should be verified there, as these figures are updated periodically.

NHS access through specialist services typically involves referral via a GP or other clinician into Tier 3 or Tier 4 weight management services, and waiting times vary. Not all patients will meet the eligibility criteria or have access to a commissioned service in their area.

For patients who do not qualify for NHS treatment, or who cannot access it within a clinically acceptable timeframe, private treatment may be the only realistic option. In that context, comparing private prices is a reasonable exercise, provided the comparison accounts for the full scope of clinical services included, not just the medication cost.

Which price details should you check before committing to a provider?

Before committing, confirm whether the price includes consultation, prescriber review and monitoring, and ask for costs at higher dose strengths. Also check for additional charges such as delivery, pen needles and sharps disposal, and verify the provider's GPhC or PSNI registration.

Before committing to any private Mounjaro provider, there are several specific details you should verify rather than relying on the headline price alone. First, confirm whether the quoted price includes the clinical consultation and prescriber review, or whether these are charged separately. A low medication price accompanied by a mandatory consultation fee may cost more overall than a bundled service.

Second, ask about the cost at higher dose strengths. Because Mounjaro is titrated from 2.5 mg up to a maximum of 15 mg weekly, the price you pay in month one may be significantly lower than what you will pay at your maintenance dose. A provider that quotes only the starting dose price without disclosing the cost trajectory is not giving you the information you need to budget accurately.

Third, check what additional costs apply beyond the medication itself. These can include delivery charges, cold-chain packaging, pen needles (which are not included in the KwikPen pack and must be obtained separately), sharps disposal bins, and any fees for follow-up appointments or cancellation and returns.^[11][12] These costs can materially change the total monthly outlay.

Fourth, check what monitoring is included. Safe prescribing of Mounjaro requires ongoing clinical review, including assessment of weight, tolerability and any emerging side effects. A service that provides the prescription but no follow-up is not meeting the standard of care that responsible prescribing requires.

Finally, verify the provider's regulatory status before sharing any personal or medical information:

• In Great Britain, the pharmacy must appear on the GPhC register (pharmacyregulation.org).

• In Northern Ireland, check the PSNI register (psni.org.uk).

• The prescribing clinician must be registered with their relevant professional body, such as the GMC (gmc-uk.org).

• In England, the clinical service may also be inspected by the Care Quality Commission (CQC); in Scotland by Healthcare Improvement Scotland; in Wales by Healthcare Inspectorate Wales; and in Northern Ireland by the Regulation and Quality Improvement Authority (RQIA).

A provider that is transparent about all of these details is demonstrating the accountability that safe private prescribing requires.

Frequently Asked Questions